Tech Company Financing Transactions
Geneos Therapeutics Funding Round
Geneos Therapeutics, operating out of Plymouth Meeting, secured $10.5 million from Sante Ventures and Inovio Pharmaceuticals.
Transaction Overview
Company Name
Announced On
2/22/2019
Transaction Type
Venture Equity
Amount
$10,500,000
Round
Series A
Investors
Sante Ventures (Lead Investor) (James Eadie)
Inovio Pharmaceuticals (Joseph Kim)
Proceeds Purpose
The Series A financing will enable the company to establish its operations and complete IND enabling activities towards the initiation of first-in-human clinical trials.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
660 West Germantown Pike LL 100
Plymouth Meeting, PA 19462
USA
Plymouth Meeting, PA 19462
USA
Phone
Undisclosed
Website
Email Address
Overview
At Geneos Therapeutics, we believe that personalized therapies are the future of cancer treatment. Our passion is to develop personalized therapies to unleash the most powerful force against cancer -- your body's own immune system.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Niranjan Sardesai
Chief Financial Officer
Federica O'Brien
VP - Bus. Development
Hakim Hammach
VP - Operations
Joann Peters
VP - R & D
Alfredo Perales-Puchalt
Browse more venture capital transactions:
Prev: 2/22/2019: DoorDash venture capital transaction
Next: 2/22/2019: WaitWhat venture capital transaction
Share this article
Where The Data Comes From
We do our best to record every notable VC transaction. All VC database entries reported here are sourced from a variety of public sources. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs